Jacob M. Berman
Mount Sinai Hospital
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Epigenetic maintenance of the injury response state in glioblastoma stem cells.
Journal: Neuro-oncology advances
Published: November 26, 2025
De novo design of potent inhibitors of clostridial family toxins.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 22, 2025
Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models.
Journal: Science translational medicine
Published: September 25, 2024
Aneuploidy selects for the acquisition of driver genes in breast cancer.
Journal: Nature
Published: August 20, 2024
Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Journal: Nature communications
Published: September 05, 2023
A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation.
Journal: Science (New York, N.Y.)
Published: October 06, 2022
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity.
Journal: Haematologica
Published: August 05, 2022
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Journal: Nature communications
Published: May 06, 2022
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer.
Journal: Nature communications
Published: July 28, 2019
Regression and Genomic Analyses on the Association Between Dose-Normalized Mycophenolic Acid Exposure and Absolute Neutrophil Count in Steroid-Free, De Novo Kidney Transplant Recipients.
Journal: Clinical drug investigation
Published: September 05, 2018
Last Updated: 09/26/2026